Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of three distinct medications that may be used together for pain management, particularly for acute pain and inflammatory conditions. While they're not formulated as a single product, they can be prescribed together as a multi-drug regimen. Celecoxib (Celebrex) is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). Acetaminophen (Tylenol) is a non-NSAID pain reliever. Dexamethasone is a corticosteroid used to treat various inflammatory conditions. The combination of these medications may provide enhanced pain relief through different mechanisms of action. Celecoxib and dexamethasone have been studied together for postoperative pain management, with both showing effectiveness. Additionally, celecoxib and acetaminophen can be safely used together, potentially allowing for lower doses of each medication and increased safety. When used in combination, these medications target pain and inflammation through different pathways: - Celecoxib selectively inhibits COX-2 enzymes - Acetaminophen has a different mechanism than NSAIDs - Dexamethasone reduces inflammation through corticosteroid action
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on celecoxib + acetaminophen + dexamethasone.